The device industry all-but-officially has one extra year to be ready to comply with the EU Medical Device Regulation. That news leads this week’s Pathways’ Picks roundup.
The amendment delaying the EU Medical Device Regulation for one year is a done deal. Meanwhile, FDA says it is assessing its ability to maintain user-fee performance goals, CMS is recommending a measured and targeted restart of elective procedures, and serological COVID-19 testing continues to face challenges. That and more in this week’s Pathways’ Picks.